Nuclear pore complex interacting protein family member A7 (NPIPA7)

NPIPA7 (Nuclear pore complex interacting protein family member A7) is identified as a protein-coding gene but has virtually no functional characterization in major genomic or proteomic databases.[4] It is part of a gene family (including NPIPA1 and NPIPA8) whose members are predicted to be associated with the nuclear pore complex (NPC). The NPC is a large protein assembly embedded in the nuclear envelope of eukaryotic cells that regulates macromolecular trafficking between the nucleus and cytoplasm.[1][5][7] However, while some related genes such as NPIPA1 are predicted to have roles in mRNA and protein transport and to be located at the nuclear membrane, there is no experimentally validated function, disease association, or therapeutic relevance documented for NPIPA7 itself.[2][4] Key notes: - There is no experimental or clinical evidence that NPIPA7 is a therapeutic target or that it participates in a recognized biological process. - NPIPA7 is not referenced in key protein function, disease, or drug interaction databases as of the latest data available. - The nomenclature confusion (aliases with NPIPA8, and repeated full name variants) and absence of established function or drug relevance indicates potential issues with target definition or curation, suggesting it may be a computationally predicted or weakly annotated gene locus. Summary: NPIPA7 is a poorly characterized gene with sequence-based prediction linking it to the nuclear pore complex-interacting protein family, but there is no clear evidence that it functions as a drug target, is clinically relevant, or even has a well-defined biological role in humans.[2][4] The lack of information and the confusion with aliases marks it as a questionable or insufficiently defined target.

Other names

NPIPA7Nuclear pore complex-interacting protein family member A7NPIPA8Nuclear pore complex-interacting protein family member A8